Skip to main content

and
  1. Article

    Open Access

    Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy

    **ao-mei Yang, Xuan-dong Lin, Wei Shi in Signal Transduction and Targeted Therapy (2023)

  2. Article

    Open Access

    ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer

    Proficient mismatch repair or microsatellite stable (pMMR/MSS) colorectal cancers (CRCs) are vastly outnumbered by deficient mismatch repair or microsatellite instability-high (dMMR/MSI-H) tumors and lack a re...

    Dan Zhang, Qi-Qi Ni, Qiao-Yan Liang, Li-Ling He, Bo-Wen Qiu, Ling-Jie Zhang in Oncogene (2023)

  3. Article

    Open Access

    Neutralizing antibodies against SARS-CoV-2 virus after vaccination in patients with neurofibromatosis type 1

    Qiao-ling Ruan, Zhi-chao Wang, Cheng-jiang Wei in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2

    Effective drugs with broad spectrum safety profile to all people are highly expected to combat COVID-19 caused by SARS-CoV-2. Here we report that nelfinavir, an FDA approved drug for the treatment of HIV infec...

    Zhijian Xu, Danrong Shi, Jian-Bao Han, Yun Ling in Signal Transduction and Targeted Therapy (2023)

  5. No Access

    Article

    Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts

    Most cases of hepatocellular carcinoma (HCC) arise with the fibrotic microenvironment where hepatic stellate cells (HSCs) and carcinoma-associated fibroblasts (CAFs) are critical components in HCC progression....

    Yao-Tsung Tsai, Chih-Yi Li, Yen-Hua Huang, Te-Sheng Chang, Chung-Yen Lin in Oncogene (2022)

  6. Article

    Open Access

    CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression

    Major gaps in understanding the molecular mechanisms of colorectal cancer (CRC) progression and intestinal mucosal repair have hampered therapeutic development for gastrointestinal disorders. Trefoil factor 3 ...

    Hong-Yong Cui, Shi-Jie Wang, Fei Song, Xu Cheng in Signal Transduction and Targeted Therapy (2021)

  7. Article

    Open Access

    Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

    Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SAR...

    Huijie Bian, Zhao-Hui Zheng, Ding Wei in Signal Transduction and Targeted Therapy (2021)

  8. Article

    Open Access

    CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

    In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2, no specific and effective drugs for treating this disease have been reported until today. Angiotensin-converting enzyme ...

    Ke Wang, Wei Chen, Zheng Zhang, Yongqiang Deng in Signal Transduction and Targeted Therapy (2020)

  9. Article

    Open Access

    Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway

    The early onset breast cancer patients (age ≤ 40) often display higher incidence of axillary lymph node metastasis, and poorer five-year survival than the late-onset patients. To identify the genes and molecul...

    Jer-Wei Chang, Wen-Hung Kuo, Chiao-Mei Lin, Wen-Ling Chen, Shih-Hsuan Chan in Oncogene (2018)